MicroPort CardioFlow Medtech Corporation (HKG:2160)
1.200
-0.060 (-4.76%)
Jun 18, 2026, 4:08 PM HKT
HKG:2160 Stock Forecast
HKG-2160's stock price has decreased by -75.51% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 2 analysts polled by S&P Global, HKG:2160 stock has a consensus rating of "Strong Buy" and an average price target of $7.07. The average 1-year stock price forecast is 489.17% higher than the current stock price, while the lowest is $6.26 (+421.67%) and the highest is $7.88 (+556.67%).
Price Target: $7.07 (+489.17%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for HKG:2160 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
43.41M
from 57.04M
Decreased by -23.89%
Revenue Next Year
47.11M
from 43.41M
Increased by 8.50%
EPS This Year
0.02
from -0.04
EPS Next Year
n/a
from 0.02
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 43.4M | ||
| Avg | 43.4M | ||
| Low | 43.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -23.9% | ||
| Avg | -23.9% | ||
| Low | -23.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.02 | ||
| Avg | 0.02 | ||
| Low | 0.02 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |